Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sanofi (SNYNF) and Mimi’s Rock (MIMNF).
Sanofi (SNYNF)
Leerink Partners analyst Geoff Porges maintained a Hold rating on Sanofi on April 29 and set a price target of EUR110.00. The company’s shares closed last Monday at $100.68.
According to TipRanks.com, Porges is a 3-star analyst with an average return of 5.6% and a 48.4% success rate. Porges covers the Healthcare sector, focusing on stocks such as Alexion Pharmaceuticals, Vertex Pharmaceuticals, and Theravance Biopharma.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sanofi with a $119.70 average price target, which is a 14.5% upside from current levels. In a report issued on April 29, Barclays also maintained a Hold rating on the stock with a EUR90.00 price target.
See today’s analyst top recommended stocks >>
Mimi’s Rock (MIMNF)
Bloom Burton analyst Antonia Borovina maintained a Buy rating on Mimi’s Rock on April 30 and set a price target of C$0.50. The company’s shares closed last Monday at $0.35, close to its 52-week high of $0.36.
Borovina has an average return of 16.5% when recommending Mimi’s Rock.
According to TipRanks.com, Borovina is ranked #3469 out of 7491 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mimi’s Rock with a $0.41 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
